Wex Pharmaceuticals Inc. Appointment Of Acting Chief Financial Officer

The Board of Directors of Wex Pharmaceuticals Inc. (the "Company") has named Robert R. Macgregor as acting Chief Financial Officer, following the departure of David G. Mathews, who is no longer with the company. Robert R. Macgregor currently serves as Controller of Wex and will serve as acting Chief Financial Officer until a permanent replacement has been hired.

Back to news